Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Bulletin of Experimental Biology and Medicine
Metadata
Title
Effect of Intravenous Laser Irradiation of the Blood on Plasma Content of Ceruloplasmin in Patients with Chronic Pancreatitis
Authors
N. M. Burduli
S. K.Gutnova
Publication date
01-11-2010
Publisher
Springer US
Published in
Bulletin of Experimental Biology and Medicine / Issue 6/2010
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-010-1027-8

Other articles of this Issue 6/2010

Bulletin of Experimental Biology and Medicine 6/2010 Go to the issue

OriginalPaper

Vascular Endothelial Growth Factor and Its Type 2 Receptor in Hepatocellular Carcinoma

PRIMATOLOGY

Blood Picture and Interferon Status of Monkeys Infected by Simian Latent Viruses

ONCOLOGY

Relationship between Proliferation of Ehrlich Ascitic Tumor Cells and Status of the Chalone System under Conditions of Modified Photoregimen

OriginalPaper

Hemorheological Effects of Ortho-Isobornyl Phenol Derivative under Conditions of Brain Ischemia in Rats

OriginalPaper

Lymphoprotective Effect of Perftoran

OriginalPaper

Therapeutic Efficacy of the Neuroprotective Plant Adaptogen in Neurodegenerative Disease (Parkinson’s Disease as an Example)

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits